News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,413 Results
Type
Article (39973)
Company Profile (282)
Press Release (650158)
Section
Business (205164)
Career Advice (2005)
Deals (35546)
Drug Delivery (90)
Drug Development (81359)
Employer Resources (169)
FDA (16263)
Job Trends (14927)
News (347166)
Policy (33226)
Tag
Academia (2559)
Alliances (49511)
Alzheimer's disease (1236)
Approvals (16196)
Artificial intelligence (132)
Bankruptcy (352)
Best Places to Work (11587)
Biotechnology (200)
Breast cancer (124)
Cancer (1109)
Cardiovascular disease (99)
Career advice (1674)
Cell therapy (236)
Clinical research (64657)
Collaboration (390)
Compensation (200)
COVID-19 (2587)
C-suite (95)
Data (1130)
Diabetes (154)
Diagnostics (6159)
Earnings (85221)
Employer resources (147)
Events (110142)
Executive appointments (310)
FDA (16804)
Funding (351)
Gene therapy (181)
GLP-1 (593)
Government (4633)
Healthcare (18835)
Infectious disease (2673)
Inflammatory bowel disease (108)
Interviews (310)
IPO (16346)
Job creations (3697)
Job search strategy (1431)
Layoffs (419)
Legal (8002)
Lung cancer (184)
Manufacturing (177)
Medical device (13241)
Medtech (13246)
Mergers & acquisitions (19275)
Metabolic disorders (411)
Neuroscience (1514)
NextGen Class of 2024 (6532)
Non-profit (4510)
Northern California (1482)
Obesity (238)
Opinion (186)
Patents (105)
People (56631)
Phase I (20036)
Phase II (28435)
Phase III (21304)
Pipeline (457)
Postmarket research (2599)
Preclinical (8530)
Radiopharmaceuticals (239)
Rare diseases (219)
Real estate (5940)
Regulatory (21882)
Research institute (2327)
Resumes & cover letters (349)
Southern California (1304)
Startups (3585)
United States (13504)
Vaccines (566)
Weight loss (175)
Date
Today (135)
Last 7 days (741)
Last 30 days (3804)
Last 365 days (35810)
2024 (32858)
2023 (40224)
2022 (51370)
2021 (55973)
2020 (54420)
2019 (46976)
2018 (35358)
2017 (32336)
2016 (31769)
2015 (37791)
2014 (31589)
2013 (26580)
2012 (28784)
2011 (29472)
2010 (27550)
Location
Africa (733)
Arizona (193)
Asia (37465)
Australia (6127)
California (3332)
Canada (1301)
China (248)
Colorado (146)
Connecticut (152)
Europe (80651)
Florida (460)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (577)
Massachusetts (2612)
Michigan (157)
Minnesota (274)
New Jersey (956)
New York (961)
North Carolina (704)
Northern California (1482)
Ohio (140)
Pennsylvania (847)
South America (1106)
Southern California (1304)
Texas (463)
Utah (90)
Washington State (362)
690,413 Results for "astrazeneca canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
AstraZeneca’s China Head Taken Into Custody by Chinese Authorities: Reports
While it remains unclear why AstraZeneca China President Leon Wang has been detained, news of his arrest comes just days after it was reported that he was under investigation for alleged medical insurance fraud in the country.
November 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
ASTRAZENECA CANADA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA TO DRIVE CHANGE IN BLOOD CANCER RESEARCH
September 12, 2024
·
4 min read
China
AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud
BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” to AstraZeneca, but contends that the share selloff is “overdone” and likely a knee-jerk reaction by investors.
November 6, 2024
·
2 min read
·
Tristan Manalac
Podcast
AbbVie’s Surprise Schizophrenia Flop, AstraZeneca’s China Drama, Hope in Huntington’s, More
A tale of two multi-billion schizophrenia deals, AstraZeneca touts strong sales while deflecting questions about an investigation into China exec, the Huntington’s pipeline builds momentum and layoffs continue with Sana Biotechnology and 23andMe.
November 13, 2024
·
1 min read
·
Heather McKenzie
Obesity
AstraZeneca Bolsters Obesity Pipeline With Promising Early Data for Candidates
While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb studies and creates a “foothold” for AstraZeneca in the weight loss space.
November 5, 2024
·
3 min read
·
Tristan Manalac
Deals
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
Fusion Pharmaceuticals Inc. announced that at a special meeting of its shareholders, held virtually earlier today, the Shareholders voted in favour of the resolution to approve the previously announced plan of arrangement with a wholly-owned subsidiary of AstraZeneca under the Canada Business Corporations Act pursuant to which AstraZeneca will acquire all of the issued and outstanding shares of Fusion.
May 29, 2024
·
4 min read
People
From Argentina to America: A Physician’s Journey to Pharma and AstraZeneca
Carlos Doti has moved countries and changed jobs, but one thing hasn’t changed. Making an impact on patient care has always been a priority for the AstraZeneca executive.
October 10, 2024
·
6 min read
·
Angela Gabriel
Cardiovascular disease
AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug
For an exclusive license to the preclinical Lp(a) disruptor, AstraZeneca is paying CSPC Pharmaceutical Group $100 million upfront and offering up to $1.92 billion in regulatory and commercial milestones.
October 7, 2024
·
2 min read
·
Tristan Manalac
Approvals
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer
The European Union has approved the first-ever combination therapy consisting of an immunotherapy and a PARP inhibitor for the treatment of endometrial cancer, AstraZeneca announced Wednesday.
August 14, 2024
·
2 min read
·
Tristan Manalac
Business
Alexion Canada Appoints Karen Heim as New General Manager
Alexion Pharma Canada Corp., AstraZeneca’s Rare Disease group, is pleased to announce the appointment of Karen Heim as Vice President and General Manager, Canada, effective April 1st, 2024.
April 2, 2024
·
3 min read
1 of 69,042
Next